HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,130.00
+186.83 (4.74%)
At close: Apr 1, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 120.3 billion as of April 1, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
120.30B
Enterprise Value
107.48B
Revenue
130.51B
Ranking
n/a
PE Ratio
10.43
Stock Price
4,130.00
Market Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 120.30B, an increase of 373.57%. That is a compound annual growth rate of 6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 126.00B | -2.21% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 156.74B |
| Kyung Dong Pharmaceutical | 147.91B |
| DongKoo Bio & Pharma | 147.11B |
| PHARMARESEARCH BIO | 132.53B |
| Pharos iBio | 129.46B |
| KOREA PHARMA | 126.52B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.43B |
| Daehan Nupharm | 101.48B |